Trade Report: The Zacks: Concord Medical Services Holdings Limited (CCM) Given Average Recommendation of “Sell” from Analysts

The Zacks: Concord Medical Services Holdings Limited (CCM) Given Average Recommendation of “Sell” from Analysts

Shares of Concord Medical Services Holdings Limited (NYSE:CCM) have been given a consensus broker rating score of 3.70 (Sell) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a sell rating.

Brokerages have set a one year consensus price objective of $4.20 for the company and are predicting that the company will post ($0.05) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Concord Medical Services Holdings Limited an industry rank of 252 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research lowered Concord Medical Services Holdings Limited from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 13th.

An institutional investor recently raised its position in Concord Medical Services Holdings Limited stock. California Public Employees Retirement System boosted its position in Concord Medical Services Holdings Limited (NYSE:CCM) by 58.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 113,100 shares of the company’s stock after buying an additional 41,700 shares during the period. California Public Employees Retirement System owned 0.26% of Concord Medical Services Holdings Limited worth $435,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 12.95% of the company’s stock.

Concord Medical Services Holdings Limited (NYSE:CCM) traded down 2.34% during midday trading on Monday, hitting $4.18. The company had a trading volume of 1,472 shares. The company’s market cap is $60.92 million. The company’s 50 day moving average is $4.10 and its 200-day moving average is $4.24. Concord Medical Services Holdings Limited has a one year low of $3.51 and a one year high of $5.80.

Concord Medical Services Holdings Limited (NYSE:CCM) last released its earnings results on Wednesday, August 24th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.21 by $0.38. Concord Medical Services Holdings Limited had a negative net margin of 35.73% and a negative return on equity of 12.54%. On average, equities analysts predict that Concord Medical Services Holdings Limited will post ($0.74) EPS for the current year.

Concord Medical Services Holdings Limited Company Profile

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.

Related posts

Leave a Comment